✉news ScienceBiology first seen 2 d ago, last 1 d ago, peak #15
WHO weighs GLP-1 use in children in latest medical roundup
Original: WHO on GLP-1s for kids; long-term opioids and back pain; feds and Big Tech back AI biology — Morning Medical Update
A morning medical news roundup leads with the World Health Organization addressing the use of GLP-1 weight-loss drugs in children, alongside reports that long-term opioid treatment for back pain is under scrutiny and that US federal agencies and major tech companies are backing AI-driven biology research. Together the items highlight ongoing debates over obesity treatment in minors, pain management standards, and the growing role of artificial intelligence in the life sciences.
Why now: Readers are following fast-moving developments in children's obesity medication, opioid prescribing, and AI in biology.
World Health OrganizationGLP-1 drugsUS federal agenciesBig Tech companies
Evidence
- WHO on GLP-1s for kids; long-term opioids and back pain; feds and Big Tech back AI biology — Morning Medical Update · Medical Economics
API: https://socialmediatrends-api.osmike.com/v1/trends/1493806